Russell Investments Group Ltd. Has $9.32 Million Stock Holdings in Teleflex Incorporated $TFX

Key Points

• Russell Investments Group Ltd. reduced its stake in Teleflex by 24.4%, currently holding 67,453 shares valued at approximately $9.32 million.
• Teleflex announced a quarterly dividend of $0.34, yielding 1.1%, with a payout ratio of 32%.
• The company reported its quarterly earnings with an EPS of $3.73, exceeding analysts' expectations and showing a revenue increase of 4.2% from the previous year.

Russell Investments Group Ltd. lessened its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 24.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,453 shares of the medical technology company's stock after selling 21,741 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.15% of Teleflex worth $9,320,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. Diamond Hill Capital Management Inc. grew its position in Teleflex by 122.8% in the first quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company's stock valued at $80,784,000 after acquiring an additional 322,222 shares during the period. T. Rowe Price Investment Management Inc. grew its position in Teleflex by 4.4% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company's stock valued at $1,098,693,000 after acquiring an additional 261,279 shares during the period. Principal Financial Group Inc. grew its position in Teleflex by 229.9% in the first quarter. Principal Financial Group Inc. now owns 230,522 shares of the medical technology company's stock valued at $31,856,000 after acquiring an additional 160,646 shares during the period. Deutsche Bank AG grew its position in Teleflex by 62.5% in the fourth quarter. Deutsche Bank AG now owns 407,129 shares of the medical technology company's stock valued at $72,461,000 after acquiring an additional 156,524 shares during the period. Finally, Public Sector Pension Investment Board grew its position in Teleflex by 2,440.9% in the first quarter. Public Sector Pension Investment Board now owns 147,298 shares of the medical technology company's stock valued at $20,355,000 after acquiring an additional 141,501 shares during the period. Institutional investors and hedge funds own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on TFX. Morgan Stanley reduced their price objective on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research note on Monday, May 5th. Truist Financial reduced their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research note on Monday, May 5th. Wall Street Zen raised Teleflex from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 2nd. Royal Bank Of Canada upped their price target on Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research note on Friday, August 1st. Finally, Wells Fargo & Company dropped their price objective on Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Teleflex has an average rating of "Hold" and a consensus price target of $141.57.

Teleflex Stock Up 3.8%

NYSE TFX traded up $4.6850 during trading hours on Friday, hitting $129.2950. 444,429 shares of the company traded hands, compared to its average volume of 791,507. The business's 50-day moving average is $117.96 and its 200-day moving average is $131.26. Teleflex Incorporated has a twelve month low of $108.90 and a twelve month high of $249.90. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The stock has a market capitalization of $5.71 billion, a price-to-earnings ratio of 30.42, a P/E/G ratio of 1.75 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, beating the consensus estimate of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The firm had revenue of $780.90 million during the quarter, compared to analysts' expectations of $771.53 million. During the same period in the prior year, the firm posted $3.42 earnings per share. The business's quarterly revenue was up 4.2% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Sell-side analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.36 annualized dividend and a yield of 1.1%. Teleflex's dividend payout ratio is 32.00%.

Insider Buying and Selling

In other Teleflex news, CEO Liam Kelly acquired 1,500 shares of the business's stock in a transaction dated Tuesday, August 5th. The stock was bought at an average cost of $115.07 per share, with a total value of $172,605.00. Following the completion of the transaction, the chief executive officer directly owned 45,267 shares in the company, valued at approximately $5,208,873.69. This represents a 3.43% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Gretchen R. Haggerty acquired 500 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was acquired at an average cost of $114.75 per share, with a total value of $57,375.00. Following the completion of the transaction, the director owned 6,305 shares of the company's stock, valued at approximately $723,498.75. The trade was a 8.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 5,500 shares of company stock valued at $633,590. Insiders own 1.40% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.